SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

23 Apr 2020 07:00

RNS Number : 5653K
Devro PLC
23 April 2020
 

23 April 2020

 

Devro plc

 

Trading Update

 

This announcement contains inside information

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January 2020 to the current date ahead of its Annual General Meeting on 30 April 2020.

The Group remains focused on protecting the well-being of its employees, their families and the wider community. Our teams have responded well to the Covid-19 crisis and their efforts and dedication have resulted in us being able to maintain the safety and continuity of our global operations.

Current trading and Covid-19 impacts

Q1 2020 edible collagen volumes increased by c. 2% compared to the prior year, driven by continued execution of growth initiatives and elevated short-term demand relating to Covid-19.

Emerging markets were up 13% led by strong growth in Latin America, Russia and East and South East Asia. Mature markets declined 3% mainly due to ongoing distributor destocking in Continental EU & West and a weaker demand environment during January and February in the UK & Ireland. North America continued to grow.

Our people are working hard to service customers in the food supply chain and all sites are currently operating. We continue to closely monitor Covid-19 developments with the key risks being preserving supply chain continuity and employee well-being, together with the potential for the nature and duration of global containment measures to affect demand. In recent weeks some suppliers have experienced disruption in their end markets. We acted decisively to secure supply, but this has resulted in some raw material inflation, which we are working to mitigate through targeted cost savings.

The Group has also instigated cash mitigation actions in response to Covid-19, including cutting all discretionary capital and operating expenditure. The company is currently not taking advantage of any Covid-19 UK government support schemes.

Financial position

Devro has a strong financial position with substantial liquidity and long-term banking facilities. The Group's debt facilities consist of a committed £105 million Revolving Credit Facility (RCF), which expires in 2023, and US$100 million of private placements expiring in 2021 (US$25 million), 2024 (US$50 million) and 2026 (US$25 million). As of Friday 17 April 2020, the Group had net debt of £130 million, comprising gross debt of £156 million and cash of £26 million. As at the date of this announcement the Group has available liquidity of c. £59 million comprising of cash and undrawn committed facilities.

Dividend

The Board is mindful of the uncertainty as to the potential for future disruption as a result of Covid-19. As a precautionary measure the Board has therefore decided to delay payment of its 2019 final dividend by withdrawing the proposed recommendation to pay a final 2019 dividend of 6.3 pence per share (c.£10.5 million cash cost) from the resolutions being put at the AGM on 30 April. Based on the Board's current knowledge, it intends to pay an additional interim dividend of the same amount in the second half of 2020. The Board will keep this under review as the Covid-19 pandemic unfolds.

Outlook

Despite our good volume growth performance in Q1, we do not envisage any change to prior volume guidance for 2020. As such, and absent any negative Covid-19 impact, the Board's expectation for good progress in 2020 is unchanged.

Devro is a global business, integrated into the crucial food supply chain and has a robust balance sheet leaving it well positioned to succeed in these uncertain times.

 

 

ENDS

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain / Nick Hasell

Tel: 07909 684 466

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEMFWEESSEEL
Date   Source Headline
24th Mar 20174:00 pmRNS2016 Annual Report
15th Mar 20175:14 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSNotification of Board changes
6th Mar 20177:00 amRNSFinal Results
21st Feb 20172:43 pmRNSHolding(s) in Company
25th Jan 20174:36 pmRNSHolding(s) in Company
11th Jan 20177:00 amRNSYear End Trading Update
21st Dec 20167:00 amRNSAppointment of Non-Executive Director
8th Dec 20164:52 pmRNSDirector/PDMR Shareholding
8th Dec 20164:15 pmRNSDirector/PDMR Shareholding
7th Dec 20164:32 pmRNSDirector/PDMR Shareholding
25th Nov 20163:01 pmRNSDirector/PDMR Shareholding
24th Nov 20163:14 pmRNSBlock listing Interim Review
23rd Nov 20161:32 pmRNSDirector/PDMR Shareholding
14th Nov 201611:36 amRNSDirector/PDMR Shareholding
10th Nov 20164:12 pmRNSDirector/PDMR Shareholding
10th Nov 20164:07 pmRNSDirector/PDMR Shareholding
10th Nov 201610:51 amRNSDirector/PDMR Shareholding
10th Nov 20167:00 amRNSTrading Update
21st Sep 20165:05 pmRNSHolding(s) in Company
18th Aug 20162:24 pmRNSDirector/PDMR Shareholding
18th Aug 20162:23 pmRNSDirector/PDMR Shareholding
11th Aug 201610:41 amRNSHolding(s) in Company
8th Aug 20162:15 pmRNSDirector/PDMR Shareholding
3rd Aug 20167:00 amRNSHalf-year Report
21st Jul 20163:53 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSTotal Voting Rights and Share Capital
23rd Jun 20163:16 pmRNSDirector/PDMR Shareholding
10th Jun 201610:18 amRNSHolding(s) in Company
25th May 20165:38 pmRNSHolding(s) in Company
24th May 201611:53 amRNSBlock listing Interim Review
23rd May 20163:33 pmRNSDirector/PDMR Shareholding
13th May 20163:33 pmRNSDirector Declaration
5th May 20164:23 pmRNSHolding(s) in Company
28th Apr 20163:54 pmRNSDirector/PDMR Shareholding
27th Apr 20164:45 pmRNSResults of Annual General Meeting
27th Apr 20167:00 amRNSTrading Update
8th Apr 20163:33 pmRNSNotification of Transactions of Directors
30th Mar 20167:00 amRNSAnnual Financial Report
29th Mar 201612:35 pmRNSFurther re: Group Finance Director Retirement
23rd Mar 201612:52 pmRNSNotification of Transactions of Directors
1st Mar 20167:00 amRNSFinal Results
17th Feb 201610:13 amRNSHolding(s) in Company
9th Feb 201612:56 pmRNSHolding(s) in Company
9th Dec 20157:00 amRNSGroup Finance Director
27th Nov 20154:30 pmRNSNotification of Transactions of Directors
24th Nov 20158:23 amRNSBlock Listing Six Monthly Return
17th Nov 20157:01 amRNSGroup Finance Director Retirement
17th Nov 20157:00 amRNSTrading update
21st Oct 20157:00 amRNSNotice of trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.